80 Biggest Movers From Yesterday

Loading...
Loading...

Gainers

  • Cassava Sciences, Inc. SAVA shares surged 133.4% to close at $7.75 on Monday after the company announced results for a Phase 2b clinical study of Sumifilam in patients with Alzheimer's disease showed statistically significant improvements in biomarkers compared to placebo.
  • Immunomedics, Inc. IMMU shares jumped 98% to close at $83.65 on Monday. Gilead Sciences, Inc. GILD announced plans to acquire Immunomedics in a deal at $21 billion.
  • Vaxart, Inc. VXRT surged 46.8% to close at $7.78 after surging around 11% on Friday. Vaxart recently announced its oral COVID-19 vaccine candidate induces potent systemic and mucosal immune response in preclinical studies.
  • NextDecade Corporation NEXT climbed 46.3% to close at $2.97.
  • Scientific Games Corp SGMS gained 39.3% to close at $26.43 after the company announced new institutional investors would take a stake in the company at $28 per share. Shares are being purchased from current shareholders.
  • J.Jill, Inc. JILL rose 37.5% to close at $0.6866 after the company announced it would avoid bankruptcy by receiving consent to conduct out of court financial restructuring.
  • Mersana Therapeutics, Inc. MRSN surged 29.6% to close at $24.17 after peer company Immunomedics, who also works to treat cancer, was acquired by Gilead.
  • Select Energy Services, Inc. WTTR gained 25.6% to close at $5.06.
  • Evogene Ltd. EVGN jumped 24.9% to close at $2.66 after climbing 12% on Friday. Evogene, last week confirmed it has secured $10 million in financing through an investment offering.
  • NantKwest, Inc. NK shares rose 22.6% to close at $8.09. NantKwest Affiliate Brink Biologics recently reported a license deal with Fresenius Kabi.
  • Lifeway Foods, Inc. LWAY rose 20.4% to close at $6.74.
  • Genocea Biosciences, Inc. GNCA surged 19.4% to close at $2.59.
  • Bicycle Therapeutics plc BCYC gained 19.3% to close at $19.08. Bicycle Therapeutics announced that a poster describing the design of the ongoing Phase I/II trial of BT8009 will be presented at the European Society for Medical Oncology (ESMO) Virtual Congress 2020.
  • Adaptimmune Therapeutics plc ADAP climbed 18.6% to close at $9.42. Adaptimmune, last month, highlighted presentation of Phase 1 trial data with ADP-A2AFP.
  • Triumph Group, Inc. TGI gained 18.6% to close at $7.71 as stocks across sectors rebounded following recent selloffs.
  • Frequency Therapeutics, Inc. FREQ surged 18.6% to close at $22.43 after the company presented results demonstrating sustained improvement in hearing loss patients treated with FX-322.
  • Nam Tai Property Inc. NTP shares climbed 18.4% to close at $10.82 after the company reported the resignation of Director and CEO due to personal reasons.
  • TRACON Pharmaceuticals, Inc. TCON shares surged 18.4% to close at $4.89. TRACON Pharmaceuticals recently announced additional $5 million private placement.
  • Minerva Neurosciences, Inc. NERV gained 18.1% to close at $3.39. reported quarterly results last month.
  • XPEL, Inc. XPEL rose 18% to close at $28.23. XPEL, last month, reported better-than-expected Q3 results.
  • Sorrento Therapeutics, Inc. SRNE climbed 17.9% to close at $7.45 after the company secured exclusive license from Mayo Clinic for antibody-drug-nanoparticle albumin-bound immune complex platform.
  • DraftKings Inc. DKNG jumped 17.3% to close at $48.62 after the company and ESPN entered into a co-exclusive content integration agreement. DraftKings will become the exclusive daily fantasy sports provider with ESPN.
  • The Container Store Group, Inc. TCS jumped 16.7% to close at $4.83.
  • ClearPoint Neuro, Inc. CLPT rose 16.5% to close at $5.23. ClearPoint Neuro reported that Danilo D'Alessandro has been appointed as CFO.
  • Lithium Americas Corp. LAC gained 16.3% to close at $8.15.
  • Overstock.com, Inc. OSTK jumped 16.2% to close at $75.73 after Needham initiated coverage on the company's stock with a Buy rating and announced a $96 price target.
  • Applied Molecular Transport Inc. AMTI gained 16.2% to close at $31.11. Applied Molecular Transport, last month, announced that first patient was dosed in Phase 2 study of oral AMT-101 in ulcerative colitis.
  • InflaRx N.V. IFRX climbed 16.1% to close at $4.33 after the company reported initiation of Phase III part of Phase II/III clinical trial with IFX-1 in severe COVID-19 induced pneumonia.
  • Clovis Oncology, Inc. CLVS gained 15.9% to close at $7.00. The FDA, last month, approved Foundation Medicine's FoundationOne Liquid CDx, which can serve as a companion diagnostic for Rubraca.
  • Harpoon Therapeutics, Inc. HARP rose 15.9% to close at $17.18.
  • Ekso Bionics Holdings, Inc. EKSO gained 15.8% to close at $5.51.
  • The Andersons, Inc. ANDE surged 15.7% to close at $19.20. BMO Capital upgraded Andersons from Market Perform to Outperform and raised the price target from $20 to $24.
  • Venus Concept Inc. VERO rose 15.6% to close at $2.44. Venus Concept tweets 'Pave the way for high patient satisfaction by adding our IPL-based photorejuvenation treatments to your suite of services. Provide the safe, comfortable, and effective anti-aging solution patients are searching for!'
  • LexinFintech Holdings Ltd. LX gained 15.4% to close at $7.86 in sympathy with the overall market amid a tech rebound and overall positive market sentiment as AstraZeneca's Phase coronavirus vaccine trial resumed.
  • Seattle Genetics, Inc. SGEN climbed 14.6% to close at $171.79 after the company announced it would collaborate with pharmaceutical giant Merck on two Oncology drugs and that Merck would invest $1 billion in the company.
  • Spartan Energy Acquisition Corp. SPAQ rose 14.6% to close at $17.39. Fisker Inc, an EV firm, is planning a merger deal with Spartan Energy next month.
  • Viela Bio, Inc. VIE rose 13.6% to close at $35.16.
  • DiamondPeak Holdings Corp. DPHC surged 13.5% to close at $28.00 following a s17% surge on Friday.
  • GameStop Corp. GME rose 13.5% to close at $6.91. Analysts at Jefferies upgraded GameStop from Hold to Buy and raised the price target from $7 to $8, while Telsey Advisory Group upgraded the stock from Market Perform to Outperform and raised the price target from $9 to $10.. GameStop, last week, reported worse-than-expected Q2 results.
  • Dynavax Technologies Corporation DVAX climbed 13.4% to close at $5.68. Valneva and Dynavax reported a commercial supply agreement for inactivated and adjuvanted COVID-19 vaccine.
  • MOGU Inc. MOGU surged 12.7% to close at $2.40 in sympathy with the overall market on a tech rebound.
  • Forte Biosciences, Inc. FBRX rose 12.6% to close at $40.42. Forte Biosciences recently announced the full publication of Phase 1/2 data in Science Translational Medicine.
  • Vir Biotechnology, Inc. VIR shares gained 12.3% to close at $31.87 after Goldman Sachs upgraded the stock from Neutral to Buy and raised its price target from $48 to $54.
  • Evofem Biosciences, Inc. EVFM rose 11.9% to close at $2.35. Evofem Biosciences shares tumbled around 23% on Friday after the company's CEO sold 122,500 shares at an average price of $3.26.
  • Priority Technology Holdings, Inc. PRTH jumped 11.8% to close at $3.32. Priority Technology recently announced it will sell its RentPayment Business to MRI Software.
  • Nikola Corporation NKLA climbed 11.4% to close at $35.79 after declining over 14% on Friday. Nikola issued a statement in response to recent short report from Hindenburg.
  • Kingsoft Cloud Holdings Limited KC gained 10.4% to close at $35.46 as the sector rebounded following selloffs in recent sessions.
  • Huami Corporation HMI rose 9.8% to close at $13.41. Huami recently named Leon Cheng Deng as CFO.
  • Fastly Inc FSLY gained 9.5% to close at $83.27 after Tiktok US announced it would be acquired by Oracle. Tiktok is Fastly's largest customer.
  • Biocept, Inc. BIOC rose 9.4% to close at $3.95. Biocept recently entered into a in-network provider agreement with Health Net Federal Services extending coverage for its liquid biopsy oncology platform to TRICARE West region network.
  • Zymeworks Inc. ZYME jumped 9% to close at $41.73 after peer company Immunomedics, who also works to treat cancer, was acquired by Gilead.
  • Cellcom Israel Ltd. CEL rose 8.8% to close at $3.48 after the company appointed Mr. Shai Amsalem as its CFO, and Mr. Eran Shenar and Ms. Diana Elsztein -Dan as members of its board.
  • Century Aluminum Company CENX rose 8.5% to close at $10.51.
  • China Natural Resources, Inc. CHNR jumped 8.2% to close at $1.19 after the company reported unaudited interim financial results for the six months ended June 30, 2020.
  • Micron Technology, Inc. MU shares climbed 6.4% to close at $49.03 after Goldman Sachs upgraded the company's stock from Neutral to Buy and announced a $58 price target.
  • NVIDIA Corporation NVDA shares rose 5.8% to close at $514.89 after the company announced plans to acquire British chipmaker Arm Ltd from SoftBank Group’s Vision Fund, in a deal valued at $40 billion.
  • RADA Electronic Industries Ltd. RADA rose 4.6% to close at $6.54 after the company announced $10 million in new orders since mid-July 2020.
  • Enlivex Therapeutics Ltd. ENLV shares gained 4.4% to close at $5.20 after gaining over 6% on Friday. Enlivex, last month, announced allowance of new US patent covering allocetra immunotherapy.
  • Oracle Corporation ORCL shares rose 4.3% to close at $59.46 amid news Bytedance has selected Oracle as its partner for the purchase of TikTok's US operations.
  • Infosys Limited INFY rose 3.8% to close at $13.24 after the company announced it will acquire GuideVision.
  • BioNTech SE BNTX gained 3.6% to close at $67.48 after the company asked the FDA for permission to expand its COVID-19 vaccine trial to 44,000 participants.
  •  

Check out these big penny stock gainers and losers

Losers

  • Nano-X Imaging Ltd. NNOX shares dipped 23.3% to close at $49.21 on Monday after climbing 33% on Friday. Nano X Imaging recently announced it has signed an agreement with SPI Medical for the deployment of 630 Nanox.ARC units in Mexico.
  • Hancock Jaffe Laboratories, Inc. HJLI dropped 16.6% to close at $0.47 after jumping around 38% on Friday. Hancock Jaffe, last month, announced one year follow-up data on two additional VenoValve patients.
  • Ruhnn Holding Limited RUHN shares declined 12.9% to close at $2.51 after the company reported FQ1 results.
  • Teligent, Inc. TLGT shares fell 12.2% to close at $1.22 after gaining around 19% on Friday. Teligent, last month, reported a loss for its second quarter.
  • Groupon, Inc. GRPN declined 12.1% to close at $28.48 as a potential sell-off following the stock increasing roughly 45% in the last month.
  • AudioEye, Inc. AEYE fell 11.9% to close at $14.60. AudioEye, last month, priced its 411,513 share common stock offering at $17.75 per share.
  • JanOne Inc. JAN fell 10.5% to close at $5.29. JanOne recently confirmed stability data of JAN101 development batch.
  • America's Car-Mart, Inc. CRMT dropped 10.4% to close at $87.90. America's Car-Mart reported quarterly results last month.
  • Harmony Biosciences Holdings, Inc. HRMY shares tumbled 9.8% to close at $39.82 after multiple firms initiated coverage on the stock with a bullish rating.
  • Tortoise Acquisition Corp. SHLL shares fell 9.5% to close at $43.25. The team behind the successful Tortoise Acquisition brought its second SPAC to the public markets Friday. Tortoise Acquisition Corp II SNPR began trading Friday.
  • IBEX Limited IBEX dipped 9.1% to close at $10.17.
  • Kala Pharmaceuticals, Inc. KALA shares fell 8.9% to close at $7.99. Jefferies downgraded Kala Pharmaceuticals from Buy to Hold and lowered the price target from $21 to $10.
  • Graf Industrial Corp. GRAF shares tumbled 8.7% to close at $26.39. Graf Industrial recently agreed to merge with Velodyne.
  • Aspira Women's Health Inc. AWH fell 8.7% to close at $2.62.
  • ClearOne, Inc. CLRO shares declined 8.6% to close at $2.23 after the company reported a $5.3 million registered direct offering priced at-the-market under Nasdaq rules.
  • Mallinckrodt PLC MNK dropped 8.3% to close at $1.10 after the FDA denied the company's new drug application to treat kidney failure.
  • Co-Diagnostics, Inc. CODX shares fell 7.5% to close at $12.68 as a potential sell-off following the stock increasing roughly 66% since last Tuesday.
  • Avinger, Inc. AVGR fell 6.8% to close at $0.3404 after declining 12% on Friday. Avinger, last month, priced 11.06 million share public offering of common stock at $0.47 per share.
  • Par Pacific Holdings, Inc. PARR shares fell 6.2% to close at $7.51. JP Morgan, on Friday, initiated coverage on Par Pacific with an Underweight rating.
Loading...
Loading...
Market News and Data brought to you by Benzinga APIs
Posted In: NewsPenny StocksPre-Market OutlookMarketsMoversTrading IdeasConsumer StaplesMovers From YesterdayPackaged Foods & MeatsTop Gainers
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...